Pharmacy in 2025 is undergoing significant changes that are redefining how pharmacists operate, manage their businesses, and care for patients. According to current pharmacy news, across multiple regions, new government regulations, targeted funding initiatives, and industry-driven reforms are emerging, each with the potential to shape the profession for years to come. Financial institutions are offering specialized credit lines to strengthen community pharmacies, while policymakers are introducing incentives for local drug production and revising pricing models to make essential medicines more accessible.
These latest developments in pharmacy cover a wide spectrum – from supporting women-owned and rural pharmacies, to encouraging domestic manufacturing of generics and biosimilars, addressing persistent drug shortages, and integrating digital health tools into patient care. Each change comes with practical implications, whether it is adjusting procurement strategies, adopting new compliance processes, or expanding the range of services offered.
For pharmacists, keeping pace with such rapid shifts is no longer just about staying updated. Rather, it is about anticipating challenges, seizing new opportunities, and aligning daily operations with evolving standards. In this roundup, we present all the latest news about pharmacy for 2025, along with concise takeaways designed to help pharmacists in every region adapt and thrive.
#1 Mail-Order Pharmacy Satisfaction on the Rise in the US
Current pharmacy news says, according to the J.D. Power 2025 U.S. Pharmacy Study, customer satisfaction with mail-order pharmacies has increased notably. Specifically, the study reports a seven-point rise on a 1,000-point scale, marking a significant improvement compared to previous years. This upward trend highlights the growing preference among patients for remote pharmacy services, driven by factors such as convenience, ease of access, and the ability to receive medications without needing to visit a physical location.
At the same time, traditional brick-and-mortar pharmacies continue to face a range of challenges, including staffing shortages, increased operational costs, and shifting patient behaviors. As a result, more patients are turning to mail-order options, which offer greater flexibility and often faster delivery.
This growing reliance on remote dispensing services reflects broader changes in healthcare consumption, emphasizing the importance of adapting pharmacy services to meet modern patient needs.
Takeaway for Pharmacists: With patient expectations evolving, pharmacists should assess opportunities to integrate or expand mail-order capabilities. Even community pharmacies can adopt hybrid models offering in-person consultations alongside mail delivery, to retain patients who might otherwise migrate entirely to online competitors. Doing so can stabilize revenue streams and maintain continuity of care in regions experiencing pharmacy deserts.
#2 Expanding Pharmacist Scope of Practice in the US
According to the latest news about pharmacy, legislative activity in 2025 has reached an all-time high for the pharmacy sector. According to the National Alliance of State Pharmacy Associations (NASPA), 44 U.S. states have introduced more than 200 bills this year to broaden pharmacists’ clinical roles.
Key proposals include:
- Authorizing pharmacists to administer all CDC-recommended vaccines without physician oversight.
- Allowing pharmacists to test and treat common illnesses such as flu, strep throat, and COVID-19.
- Enabling collaborative practice agreements to allow pharmacists to initiate or adjust chronic disease medications.
This latest pharmacy news on expansion follows growing recognition of pharmacists’ accessibility and ability to alleviate pressure on overburdened healthcare systems.
Takeaway for pharmacists: Expect more autonomy in patient care and be prepared to update your clinical and diagnostic skills.
#3 New Special Container Requirements for Specific Medications in the UK
The UK’s Department of Health and Social Care has reclassified several medicines, including multiple strengths of Alkindi® hydrocortisone granules and ipratropium bromide nebuliser vials, as special containers under Part II Clause 10B of the Drug Tariff.
This means these products must now be dispensed in their full original packs or specific sub-packs rather than in exact prescribed quantities, with reimbursement calculated accordingly. The change impacts how pharmacies order, store, and dispense these medicines, requiring careful adjustments to inventory management and dispensing workflows.
Takeaway for Pharmacists: This latest news about pharmacy serves as an important reminder for UK-based pharmacists to review and improve their inventory and dispensing procedures. Aligning these protocols with the new special container reclassification is essential to ensure compliance with funding regulations and to maintain efficient pharmacy operations.
#4 Pharmacy Closures Accelerate in Germany
Current pharmacy news from the ABDA’s Statistical Yearbook confirms a worrying trend. Germany’s pharmacy count has dropped from 17,041 at the end of 2024 to approximately 16,803 by mid-2025. The first half of 2025 alone saw 271 closures and only 33 new openings, continuing a five-year decline totaling more than 2,000 pharmacies.
Takeaway for Pharmacist: Expect increased pressure on remaining community pharmacies. It is critical to reinforce your value in the local healthcare ecosystem and explore new service offerings to safeguard your practice.
#5 EIB Launches €200 Million Boost for Italian Pharmacies
According to the latest news in pharmacy 2025, the European Investment Bank (EIB) announced a landmark financing initiative designed to strengthen Italy’s pharmacy network. The plan involves a €100 million credit line from the EIB to Banca Ifis, which will match the amount, creating a total funding pool of €200 million. This is the first time the EIB has dedicated a finance line exclusively to the Italian pharmacy sector.
At least 30% of the total funding (€60 million) is earmarked for pharmacies owned or managed by women, reflecting a commitment to boost female entrepreneurship in healthcare. This targeted support will be particularly focused on underserved, remote, and economically weaker regions where access to medical services is limited, ensuring that community pharmacies can continue to serve as vital access points for healthcare.
The funding is intended to support pharmacies in modernizing their operations, adopting advanced technologies, and expanding service offerings like telemedicine and health screenings. It also aims to help pharmacies follow evolving health regulations. Enhancing resilience and improving accessibility are key goals of this initiative, designed to reinforce pharmacies as trusted community health centers. This support is especially crucial given the recent medicine shortages and supply chain disruptions that have placed significant strain on Italy’s healthcare system.
Takeaway for Pharmacists: This latest news about pharmacy funding is an excellent opportunity for Italian pharmacists, especially women owners. Why? It is because this can help them secure affordable financing for modernization, service expansion, and technology upgrades.
#6 France to Boost Prices for Locally Made Medicines
France’s Economic Committee for Health Products (CEPS) is preparing a detailed report on the country’s drug pricing system to guide the 2026 Social Security Finance Bill (PLFSS).
One of the most significant proposed changes is the introduction of a preferential pricing policy for medicines manufactured domestically. This means drugs produced in France, whether branded, generic, or biosimilar, would receive more favorable price agreements than those entirely imported.
The goal is to encourage pharmaceutical companies to expand local manufacturing, strengthen supply security, and reduce reliance on overseas suppliers, especially for active pharmaceutical ingredients often sourced from Asia.
Takeaway for Pharmacists: Pharmacists could see more stable supplies and potentially faster access to domestically produced medicines as manufacturers shift production to France. This policy may also expand the range of locally made generics and biosimilars available, giving pharmacists more options to meet patient needs while supporting national health sovereignty.
MDForLives: Your One-Stop Destination for Latest News in Pharmacy
With the rapid and ongoing changes transforming the pharmacy sector in 2025, knowing every latest development in pharmacy has become more important than ever. Pharmacists face evolving regulations, shifting market dynamics, and new technologies that can significantly impact their daily operations and patient care responsibilities. MDForLives serves as a reliable and comprehensive resource, delivering a continuous flow of accurate, relevant news and in-depth analysis tailored specifically for pharmacy professionals.
Whether you need timely updates on legislative reforms, insights into new funding and financing opportunities, or the latest developments in digital health and pharmaceutical technologies, MDForLives provides the clarity and context necessary to understand how these factors affect your practice.
Making MDForLives your primary source for the latest news about pharmacy equips you to navigate industry changes confidently, adapt your strategies effectively, and capitalize on emerging trends and opportunities throughout the year and beyond.
MDForLives is a vibrant community of healthcare professionals and patients dedicated to shaping the future of healthcare. We provide valuable global insights to healthcare companies through online surveys, interviews, and discussion forums.
